Protecting your HIV negative status: Leave no stone unturned – An Unfinished Story
Raphael J. Landovitz, MD MSc
Associate Professor of Medicine
Division of Infectious Diseases
Center for Clinical AIDS Research & Education
David Geffen School of Medicine
Date/Time (PLEASE NOTE NEW TIME):
Thursday, May 2, 2013
12:00pm to 2:00 pm
It is a one hour presentation, followed by a community panel discussion and Q & A session.
(NO REGISTRATION NEEDED, OPEN MEETING)
St. Anne’s Maternity Home – Foundation Conference Room
155 N. Occidental Blvd.
Los Angeles, CA 90026
Over the past several years, there have been significant advances in biomedical HIV research. The presentation will highlight key findings from various national and international trials, including those of Treatment as Prevention (TasP), Pre-exposure Prophylaxis (PrEP), and Topical Microbicides. Also information regarding ongoing demonstration projects in Los Angeles on such combination prevention approaches will be shared. The presentation will be followed by a community panel discussion to contextualize these data and projects with regard to the prevention priorities of the County and most-affected communities in Los Angeles.
Dr. Raphael J. Landovitz graduated from Princeton University in 1992, received his M.D. from Harvard Medical School in 1996, and a Master of Science in Clinical Research from UCLA in 2009. He trained at Brigham and Women’s Hospital in Boston, Massachusetts in Internal Medicine, and completed subspecialty training in Infectious Diseases and HIV at the Brigham and Women’s Hospital and the Massachusetts General Hospital. Dr. Landovitz additionally served as Chief Medical Resident at Brigham and Women’s Hospital, and continued on as staff in the Division of Infectious Disease as an Infectious Disease and HIV care provider and clinical researcher. He also served as Medical Co-Director of the Vietnam-CDC-Harvard Medical School-AIDS-Partnership, helping to train Vietnamese physicians in HIV care and treatment. At UCLA, Dr. Landovitz serves as the Intervention Core co-director for the UCLA Center for HIV Identification, Prevention, and Treatment Serivices (CHIPTS), and sees patients at the UCLA Center for Clincal AIDS Research & Education. His research focuses on HIV prevention; in particular, combination prevention strategies which include chemoprophylaxis. He developed and piloted a community-based post-exposure prophylaxis (PEP) program in Los Angeles County, and is currently studying community-based pre-exposure prophylaxis and combination HIV prevention interventions. He works with the AIDS Clinical Trials Group (ACTG), the Adolescent Trials Network (ATN) and HIV Prevention Trials Network (HPTN) and was awarded the John Carey Young Investigator Award by the ACTG in 2010